Table 1. Structures and LSD1 inhibitory activities of compounds 1–35.
R1 | R2 | LSD1 IC50 (μM) | |
---|---|---|---|
1 | 4-OBn | (4-methylpiperazin-1-yl)-carbonylmethyl | 0.0098 |
2 | 4-(6-F-pyridin-3-yl) | same as above | 0.077 |
3 | 4-Br | same as above | 0.035 |
4 | 4-(6-Cl-pyridin-3-yl) | same as above | 0.15 |
5 | 2-Br | same as above | >100 |
6 | 3-Br | same as above | >100 |
7 | 4-OBn | -H | 0.91 |
8 | 6-F-pyridin-3-yl | -H | 5.3 |
9 | 4-Br | -H | 25 |
10 | 4-Br | (piperazin-1-yl)-carbonylmethyl | 0.064 |
11 | 4-Br | (piperidin-1-yl)-carbonylmethyl | 0.62 |
12 | 4-Br | (pyrrolidin-1-yl)-carbonylmethyl | 3.6 |
13 | 4-H | same as 10 | 0.19 |
14 | 4-H | same as 11 | 1.3 |
15 | 4-Br | (piperidin-4-yl)-methyl | 0.26 |
16 | 4-H | same as above | 0.062 |
17 | 4-Br | -Bn | 5.0 |
18 | 4-Br | -(4-OH)-Bn | 94 |
19 | 4-Br | -(4-NH2)-Bn | >100 |
20 | 4-Br | -(4-NMe2)-Bn | 71 |
21 | 4-Br | (pyridin-4-yl)-methyl | >100 |
22 | 4-Br | -COCH3 | 15.4 |
23 | 4-Br | -CONHPh | 7.4 |
24 | 4-Br | = CH-Ph | 15.6 |
25 | 4-Br | = CH-(4-Br-Ph) | 1.2 |
26 | 4-Br | = CH-(2-OMe-Ph) | 0.74 |
27 | 4-Br | = CH-(3-OMe-Ph) | 0.90 |
28 | 4-Br | = CH-(2,3,4-OMe-Ph) | 94 |
29 | 4-Br | = CH-(4-NMe2-Ph) | 11 |
30 | 4-Br | = CH-(pyridine-4-yl) | 14 |
31 | 4-H | -NH2 | 5.8 |
32 | 4-H | (piperazin-1-yl)-carbonylmethylamino | 0.67 |
33 | 4-H | (piperazin-1-yl)-carboxamido | 84 |
34 | 4-Br | (piperidin-4-yl)-methylamino | 1.7 |
35 | 1-(4-methylpiperazin-1-yl)-2-((3-phenylprop-2-yn-1-yl)amino)ethan-1-one | 36.4 |